SCI时时刷

search
Dual inhibition of HERs and PD-1 counteract resistance in KRASG12C-mutant head and neck cancer
Dual inhibition of HERs and PD-1 counteract resistance in KRASG12C-mutant head and neck cancer
Basket clinical trials targeting the KRASG12C-mutation in solid tumors have shown initial promise, including in orphan KRA...
METTL14 suppresses the expression of YAP1 and the stemness of triple-negative breast cancer
METTL14 suppresses the expression of YAP1 and the stemness of triple-negative breast cancer
Triple-negative breast cancer (TNBC) has pronounced stemness that is associated with relapse. N6-methyladenosine (m6A) pla...
S1PR1 suppresses lung adenocarcinoma progression through p-STAT1/miR-30c-5 p/FOXA1 pathway
S1PR1 suppresses lung adenocarcinoma progression through p-STAT1/miR-30c-5 p/FOXA1 pathway
Sphingosine-1-phosphate receptor 1 (S1PR1) is considered to be closely related to a variety of malignant tumors, but the r...
The KLF16/MYC feedback loop is a therapeutic target in bladder cancer
The KLF16/MYC feedback loop is a therapeutic target in bladder cancer
Bladder cancer (BLCA) is a common malignancy characterized by dysregulated transcription and a lack of effective therapeut...
The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma
The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma
Among blood cancers, multiple myeloma (MM) represents the second most common neoplasm and is characterized by the accumula...
MCPIP1 modulates the miRNA‒mRNA landscape in keratinocyte carcinomas
MCPIP1 modulates the miRNA‒mRNA landscape in keratinocyte carcinomas
Monocyte Chemotactic Protein 1-Induced Protein 1 (MCPIP1, also called Regnase-1) is a negative modulator of inflammation w...
Noval insights and therapeutic strategies for tumor-induced kidney pathologies
Noval insights and therapeutic strategies for tumor-induced kidney pathologies
Recent progress in elucidating the role of specific antidiuretic hormones in Drosophila models has provided valuable insig...
NAT10/ac4C/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addiction
NAT10/ac4C/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addiction
N4-Acetylcytidine (ac4C), a highly conserved post-transcriptional mechanism, plays a pivotal role in RNA modification and ...